BillionToOne YCアプリケーション

Summer 2017Public

BillionToOneはSummer 2017バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Summer 2017
業界: HealthcareDiagnostics
チーム規模: 300
ステータス: Public
ローンチ済み: 2016

創業者

Oguzhan AtayFounder
David TsaoFounder/CTO

BillionToOneの事業内容

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

BillionToOneのYCアプリケーション、再構築済み

Y Combinator 申請

BillionToOne 様、Summer 2017 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

BillionToOne

Describe what your company does in 50 characters or less.

The genetic testing platform detecting and measuring disease.

What is your company going to make? Please describe your product and what it does or will do.

We have built a DNA molecular counter that improves the resolution of cell-free DNA diagnostics by over a thousand times. Our main product, UNITY Screen, is a non-invasive prenatal test that uniquely assesses fetal risk for recessive conditions and chromosomal abnormalities from maternal blood. We are expanding this technology into liquid biopsy tests for cancer, aiming to transform how oncology care detects and monitors disease.

Where do you live now, and where would the company be based after YC?

We currently live and work in Menlo Park, CA, and would keep the company based there after YC.

Explain your decision regarding location.

We are based in Menlo Park because it provides access to top scientific talent and proximity to leading healthcare and biotech partners, which is critical for developing and refining our complex diagnostics technology.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

BillionToOneの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、BillionToOneの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。BillionToOneのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。